-
1021
Structural engineering of stabilized, expanded epitope nanoparticle vaccines for HPV
Published 2025-01-01Get full text
Article -
1022
-
1023
-
1024
-
1025
-
1026
A minimal gene set characterizes TIL specific for diverse tumor antigens across different cancer types
Published 2025-02-01“…Abstract Identifying tumor-specific T cell clones that mediate immunotherapy responses remains challenging. Mutation-associated neoantigen (MANA) -specific CD8+ tumor-infiltrating lymphocytes (TIL) have been shown to express high levels of CXCL13 and CD39 (ENTPD1), and low IL-7 receptor (IL7R) levels in many cancer types, but their collective relevance to T cell functionality has not been established. …”
Get full text
Article -
1027
-
1028
Integrated proteogenomic characterization of ampullary adenocarcinoma
Published 2025-01-01Get full text
Article -
1029
-
1030
Novel biomarkers: the RUNX family as prognostic predictors in colorectal cancer
Published 2024-12-01“…While biomarkers have been shown to enhance the prognosis of patients with colorectal cancer (CRC) compared to conventional treatments, there is a pressing need to discover novel biomarkers that can assist in assessing the prognostic impact of immunotherapy and in formulating individualized treatment plans. …”
Get full text
Article -
1031
Elephantiasis nostra verrucosa in sclerodermatous chronic graft-versus-host disease
Published 2025-03-01Get full text
Article -
1032
Achieving chronic hepatitis B functional cure: Factors and potential mechanisms
Published 2025-01-01Get full text
Article -
1033
Evasion of Early Antiviral Responses by Herpes Simplex Viruses
Published 2015-01-01Get full text
Article -
1034
Liposomal encapsulation of cholecalciferol mitigates in vivo toxicity and delays tumor growth
Published 2025-01-01Get full text
Article -
1035
The Effect of Irisin as a Metabolic Regulator and Its Therapeutic Potential for Obesity
Published 2021-01-01Get full text
Article -
1036
Modulation of Tumor Immunity by Soluble and Membrane-Bound Molecules at the Immunological Synapse
Published 2013-01-01Get full text
Article -
1037
Usability and Usefulness of a Symptom Management Coaching System for Patients With Cancer Treated With Immune Checkpoint Inhibitors: Comparative Mixed Methods Study
Published 2025-01-01“…ResultsWe included 21 participants in the study, aged 29 to 73 years; 13 participants who had received immunotherapy and 8 participants who had not received immunotherapy. …”
Get full text
Article -
1038
-
1039
-
1040